Biotech China 2014

Immunology: University of Pittsburgh

Total Score People Score Events Score
21 13 15
Date Event Presentation Speakers
October 28, 2013 Tumor Immunology and Immunotherapy Disease associated antigens as targets for cancer immunosurvellance and candidates for prophylactic cancer vaccines Olivera J. Finn
May 5, 2011 Biologic Therapies Summit IV: Current Agents and Future Targets Combination Nonbiologic DMARDS | A Cost- Effective Alternative in RA Is Logical Larry Moreland
Lessons from Granulomatous Infections Joanne L. Flynn
February 26, 2011 Immunity in the Respiratory Tract: Challenges of the Lung Environment (X6) Vaccines Inducing Pathogen-Specific Lung Immunity | Balancing Mucosal Immunity in a Vaccine Context Jay K. Kolls
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) Immunity in Respiratory Tract (X6) | Balancing Mucosal Immunity in a Vaccine Context Jay K. Kolls
November 30, 2010 Tumor Immunology in Conjunction with the Cancer Immunology Working Group of the AACR Immunoprevention based on tumor associated antigens Olivera J. Finn
Session 2: Premalignant Lesions and Prevention Olivera J. Finn
Polarized dendritic cells in cancer therapy: Getting dendritic cells to lymph nodes and effector cells to tumors Pawel Kalinski
Treg depletion and restoration of multifunctional T cell responses in patients with cancer Theresa L. Whiteside
Session 8: Regulation of Immune Responses in Cancer: A Translational Paradigm Theresa L. Whiteside
November 30, 2010 Tumor Immunology: Basic and Clinical Advances in Conjunction with the Cancer Immunology Working Group of the AACR Immunoprevention based on tumor associated antigens Olivera J. Finn
Session 1: Premalignant Lesions and Prevention Olivera J. Finn
Polarized dendritic cells in cancer therapy: Getting dendritic cells to lymph nodes and effector cells to tumors Pawel Kalinski
Treg depletion and restoration of multifunctional T cell responses in patients with cancer Theresa L. Whiteside
Session 7: Regulation of Immune Responses in Cancer: A Translational Paradigm Theresa L. Whiteside
October 3, 2010 4th Vaccine and ISV Annual Global Congress Cancer vaccines: a tractable solution for an intractable problem | Session 3 Olivera J. Finn
October 3, 2010 From Fetomaternal Tolerance to Immunomodulatory Properties of Placenta-Derived Cells in Cell Therapy SESSION III: Stem cell biology and immunological characteristics of cells from different placental regions Stephen Strom
Amnion-derived cells to treat liver disease Stephen Strom
August 18, 2009 Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines A Systematic Approach to Biomarker Discovery: Preamble to “iSBTc-FDA Taskforce on Immunotherapy Biomarkers” Lisa H. Butterfield
Expert Panel Discussion: Commonalities and Lessons Learned from Infectious Disease and Cancer Immunotherapy and Vaccine/Immunotherapy Development Programs Robert J. Binder
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Genetic Mechanism with Huntington Disease Patients:Track 2-5 Gettig Elizabeth
Genetic Mechanism with Huntington Disease Patients :Track 2-5 Gettig Elizabeth
August 18, 2008 Systems Integration in Biodefense Building an Effective Partnership between the Private Sector and Government for Biodefense Countermeasure Development Bradley T. Smith
May 30, 2008 ASCO Annual'08 Meeting lymphoma and plasma cell disorders-- Prevention and Treatment of Bone Disease in Myeloma (M21) G. David Roodman
meet the professor sessions-- Prevention and Treatment of Bone Disease in Myeloma (M21) G. David Roodman
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases Workshop Elodie Ghedin
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases Workshop Elodie Ghedin
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases Workshop Elodie Ghedin
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.